Compare Lucid Group Inc (LCID) vs Neurocrine Biosciences Inc (NBIX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Lucid Group Inc vs Neurocrine Biosciences Inc — how do they compare? Lucid Group Inc trades at $7.34 (market cap $2.77B), while Neurocrine Biosciences Inc trades at $179 (market cap $17.40B). The key difference: Neurocrine Biosciences Inc is far larger — about 6.3× Lucid Group Inc's market cap, and Neurocrine Biosciences Inc is trading nearer its 52-week high, Lucid Group Inc nearer its low. Which is the better fit depends on your goals.
| LCID | NBIX | |
|---|---|---|
Market Cap | $2.77B | $17.40B |
Sector | Consumer Cyclical | Health |
52-Week High | $31.30 | $180.55 |
52-Week Low | $4.62 | $123.10 |
Enterprise Value | $5.24B | $16.49B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Lucid Group (LCID) trades at $7.32, down 0.54% on the day, with a bullish technical signal from moving averages but neutral oscillators. The company reported a net loss of $2.70 billion on $1.35 billion revenue in 2025, with negative profit margins and cash flow. Recent news highlights multiple class action lawsuits filed against the company, alleging securities fraud between February and April 2026.
The outlook remains challenged by persistent losses and high cash burn, though the consensus price target of $10.50 suggests potential upside. Key risks include ongoing litigation, competitive pressures in the EV market, and the need for additional financing to sustain operations amid negative cash flows.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Lucid Group Inc
Lucid Group Inc is a technology and automotive company. It develops the next generation of electric vehicle (EV) technologies. It is a vertically integrated company that designs, engineers, and builds electric vehicles, EV powertrains, and battery systems in-house using our own equipment and factory.
Read more on LCID →About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →
